Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.

Accurate knowledge of prior population exposure has critical ramifications for preparedness plans for future SARS-CoV-2 epidemic waves and vaccine prioritization strategies. Serological studies can be used to estimate levels of past exposure and thus position populations in their epidemic timeline....

Full description

Saved in:
Bibliographic Details
Main Authors: Siyu Chen, Jennifer A Flegg, Lisa J White, Ricardo Aguas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-09-01
Series:PLoS Computational Biology
Online Access:https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1009436&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850180682430545920
author Siyu Chen
Jennifer A Flegg
Lisa J White
Ricardo Aguas
author_facet Siyu Chen
Jennifer A Flegg
Lisa J White
Ricardo Aguas
author_sort Siyu Chen
collection DOAJ
description Accurate knowledge of prior population exposure has critical ramifications for preparedness plans for future SARS-CoV-2 epidemic waves and vaccine prioritization strategies. Serological studies can be used to estimate levels of past exposure and thus position populations in their epidemic timeline. To circumvent biases introduced by the decay in antibody titers over time, methods for estimating population exposure should account for seroreversion, to reflect that changes in seroprevalence measures over time are the net effect of increases due to recent transmission and decreases due to antibody waning. Here, we present a new method that combines multiple datasets (serology, mortality, and virus positivity ratios) to estimate seroreversion time and infection fatality ratios (IFR) and simultaneously infer population exposure levels. The results indicate that the average time to seroreversion is around six months, IFR is 0.54% to 1.3%, and true exposure may be more than double the current seroprevalence levels reported for several regions of England.
format Article
id doaj-art-ea7bfb18fac247b1bbdf9d50e3f708ee
institution OA Journals
issn 1553-734X
1553-7358
language English
publishDate 2021-09-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Computational Biology
spelling doaj-art-ea7bfb18fac247b1bbdf9d50e3f708ee2025-08-20T02:18:04ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582021-09-01179e100943610.1371/journal.pcbi.1009436Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.Siyu ChenJennifer A FleggLisa J WhiteRicardo AguasAccurate knowledge of prior population exposure has critical ramifications for preparedness plans for future SARS-CoV-2 epidemic waves and vaccine prioritization strategies. Serological studies can be used to estimate levels of past exposure and thus position populations in their epidemic timeline. To circumvent biases introduced by the decay in antibody titers over time, methods for estimating population exposure should account for seroreversion, to reflect that changes in seroprevalence measures over time are the net effect of increases due to recent transmission and decreases due to antibody waning. Here, we present a new method that combines multiple datasets (serology, mortality, and virus positivity ratios) to estimate seroreversion time and infection fatality ratios (IFR) and simultaneously infer population exposure levels. The results indicate that the average time to seroreversion is around six months, IFR is 0.54% to 1.3%, and true exposure may be more than double the current seroprevalence levels reported for several regions of England.https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1009436&type=printable
spellingShingle Siyu Chen
Jennifer A Flegg
Lisa J White
Ricardo Aguas
Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
PLoS Computational Biology
title Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
title_full Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
title_fullStr Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
title_full_unstemmed Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
title_short Levels of SARS-CoV-2 population exposure are considerably higher than suggested by seroprevalence surveys.
title_sort levels of sars cov 2 population exposure are considerably higher than suggested by seroprevalence surveys
url https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1009436&type=printable
work_keys_str_mv AT siyuchen levelsofsarscov2populationexposureareconsiderablyhigherthansuggestedbyseroprevalencesurveys
AT jenniferaflegg levelsofsarscov2populationexposureareconsiderablyhigherthansuggestedbyseroprevalencesurveys
AT lisajwhite levelsofsarscov2populationexposureareconsiderablyhigherthansuggestedbyseroprevalencesurveys
AT ricardoaguas levelsofsarscov2populationexposureareconsiderablyhigherthansuggestedbyseroprevalencesurveys